Kalayoglu MV - Search Results

1

Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study.

Granit V, Benatar M, Kurtoglu M, Miljković MD, Chahin N, Sahagian G, Feinberg MH, Slansky A, Vu T, Jewell CM, Singer MS, Kalayoglu MV, Howard JF Jr, Mozaffar T; MG-001 Study Team. Granit V, et al. Among authors: kalayoglu mv. Lancet Neurol. 2023 Jul;22(7):578-590. doi: 10.1016/S1474-4422(23)00194-1. Lancet Neurol. 2023. PMID: 37353278 Free PMC article. Clinical Trial.

2

Infection, inflammation and age-related macular degeneration.

Kalayoglu MV, Miller JW. Kalayoglu MV, et al. Clin Exp Ophthalmol. 2007 Jan-Feb;35(1):3-4. doi: 10.1111/j.1442-9071.2007.01432.x. Clin Exp Ophthalmol. 2007. PMID: 17300563 No abstract available.

3

Identification of Chlamydia pneumoniae within human choroidal neovascular membranes secondary to age-related macular degeneration.

Kalayoglu MV, Bula D, Arroyo J, Gragoudas ES, D'Amico D, Miller JW. Kalayoglu MV, et al. Graefes Arch Clin Exp Ophthalmol. 2005 Nov;243(11):1080-90. doi: 10.1007/s00417-005-1169-y. Epub 2005 May 21. Graefes Arch Clin Exp Ophthalmol. 2005. PMID: 15909160

4

Treatment of vitreoretinal disorders in the developing world: indications and outcomes of vitreoretinal surgery in Nepal.

Paudyal G, Doshi V, Shrestha MK, Kalayoglu MV, Tabin G, Gurung R, Shrestha B, Ruit S. Paudyal G, et al. Among authors: kalayoglu mv. Ophthalmology. 2005 Feb;112(2):319-26. doi: 10.1016/j.ophtha.2004.08.018. Ophthalmology. 2005. PMID: 15691570

5

Treatment of chlamydial eye infections.

Kalayoglu MV, Pavan-Langston D, Miller JW. Kalayoglu MV, et al. Int Ophthalmol Clin. 2004 Summer;44(3):135-46. doi: 10.1097/00004397-200404430-00013. Int Ophthalmol Clin. 2004. PMID: 15211182 Review. No abstract available.

6

Chlamydial heat shock protein 60 and lipopolysaccharide: potential virulence determinants in atherogenesis.

Kalayoglu MV. Kalayoglu MV. Curr Drug Targets Inflamm Allergy. 2002 Sep;1(3):249-55. doi: 10.2174/1568010023344652. Curr Drug Targets Inflamm Allergy. 2002. PMID: 14561189 Review.

7

Serological association between Chlamydia pneumoniae infection and age-related macular degeneration.

Kalayoglu MV, Galvan C, Mahdi OS, Byrne GI, Mansour S. Kalayoglu MV, et al. Arch Ophthalmol. 2003 Apr;121(4):478-82. doi: 10.1001/archopht.121.4.478. Arch Ophthalmol. 2003. PMID: 12695244

8

Ocular chlamydial infections: pathogenesis and emerging treatment strategies.

Kalayoglu MV. Kalayoglu MV. Curr Drug Targets Infect Disord. 2002 Mar;2(1):85-91. doi: 10.2174/1568005024605918. Curr Drug Targets Infect Disord. 2002. PMID: 12462156 Review.

9

Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.

Kalayoglu MV, Libby P, Byrne GI. Kalayoglu MV, et al. JAMA. 2002 Dec 4;288(21):2724-31. doi: 10.1001/jama.288.21.2724. JAMA. 2002. PMID: 12460096 Review.

10

Chlamydia pneumoniae-infected monocytes exhibit increased adherence to human aortic endothelial cells.

Kalayoglu MV, Perkins BN, Byrne GI. Kalayoglu MV, et al. Microbes Infect. 2001 Oct;3(12):963-9. doi: 10.1016/s1286-4579(01)01458-7. Microbes Infect. 2001. PMID: 11580983 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters